Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Major Depression Disorder: early-phase trial registry

2 of 2 indexed Major Depression Disorder trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Major Depression Disorder: 2 US clinical trials tracked, 2 recruiting.

Major Depression Disorder is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Deepak C. D'Souza, running 1 of these trials.

Enrollment posture brief

Registry condition major-depression-disorder

OPEN 2 | RECR 100% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Major Depression Disorde (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Major Depression Disorder

Major Depression Disorder lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Major Depression Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Major Depression Disorder is recruiting above its size-band peers.

    2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Named interventions

Most-linked intervention names on Major Depression Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

IV Ketamine Drug
1 trials
Spravato Drug
1 trials
THC-Low Dose Drug
1 trials
THC-Medium Dose Drug
1 trials
DMT-Low Dose Drug
1 trials
DMT-Medium Dose Drug
1 trials

US sites by state

Facility locations filed on Major Depression Disorder trials. A trial with sites in several states counts in each.

Connecticut 2 trials
Texas 1 trials
Oklahoma 1 trials
Michigan 1 trials
Georgia 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Major Depression Disorder page

2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 2 Major Depression Disorder trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Deepak C. D'Souza sponsors the most Major Depression Disorder trials on record, review their full trial history before evaluating a specific study. See Deepak C. D'Souza's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Major Depression Disorder condition card totals 2 registered trials; most-linked intervention IV Ketamine; top US site state Connecticut. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.